AI in Health Care Efficiency and Study Act

Bill Number

H.R. 7064

Origin Chamber

House

Congress

119th Congress, Session 2

Policy Area

Health

Status

Introduced

Latest Action

2026-01-14: Referred to the House Committee on Energy and Commerce.

Last Updated

2026-02-10T09:05:41Z

AI-Generated Summary

Purpose

The AI in Health Care Efficiency and Study Act (H.R. 7064) aims to direct the Secretary of Health and Human Services (HHS) to study how artificial intelligence (AI) technologies can streamline administrative and clerical tasks in the healthcare industry, such as scheduling and claims processing, while ensuring the privacy and security of patient data. The goal is to reduce costs, provider burnout, and operational inefficiencies without compromising patient protections under laws like the Health Insurance Portability and Accountability Act (HIPAA), which sets standards for handling protected health information.

Key Provisions

• Study Requirement: HHS must complete a study within 18 months of the bill's enactment, focusing on AI applications across healthcare providers, health plans, and other entities covered by HIPAA (e.g., organizations that handle patient data).
• Study Contents:
• Evaluate strategies to reduce administrative burdens in tasks like scheduling, claims processing, documentation, and prior authorizations.
• Assess improvements to patient record-keeping, including electronic health records, for better accuracy, speed, and compatibility between systems.
• Ensure AI tools comply with HIPAA privacy rules and standards from the National Institute of Standards and Technology (NIST), which develops guidelines for technology security.
• Examine AI's role in detecting and preventing cyber threats, such as ransomware attacks, data breaches, and other risks to healthcare systems.
• Consultation Process: The Secretary must consult with experts, including leaders from NIST, the National Institutes of Health, the Agency for Healthcare Research and Quality, HHS offices on technology and civil rights, academic institutions, AI developers, civil rights specialists, healthcare providers, hospital groups, IT vendors, nonprofit researchers, and patient privacy advocates.
• Reporting: Within 6 months of completing the study, HHS must submit a report to the House Committee on Energy and Commerce and the Senate Committee on Health, Education, Labor, and Pensions. The report will include:
• Findings on risks, opportunities, and challenges.
• Review of current AI tools, their effectiveness, limitations, and impact on provider workload.
• Suggestions for future HHS-led research or pilot programs.
• Policy recommendations for Congress and HHS to promote AI development, testing, implementation, and oversight, emphasizing efficiency and data protections.

Significant Changes to Existing Law

This bill introduces no direct changes to current laws. It mandates a study and report, building on existing frameworks like HIPAA (which regulates patient data privacy) without altering regulations, penalties, or enforcement mechanisms. It encourages alignment with NIST standards but does not create new mandatory rules.

Potential Impacts

• On Government Agencies: HHS will need to allocate resources for the study and consultations, potentially leading to future guidance or programs that influence how federal healthcare initiatives (e.g., Medicare and Medicaid) incorporate AI. This could streamline agency operations but increase short-term administrative workload.
• On Citizens: Patients may benefit from faster, more accurate healthcare services and stronger protections against data breaches, reducing risks like identity theft from cyber attacks. Healthcare providers could experience less burnout, allowing more focus on patient care, though adoption of AI might raise concerns about job changes for clerical staff.
• On International Relations: Minimal direct impact, as the bill focuses on domestic U.S. healthcare. However, it could indirectly influence global AI standards in health by promoting U.S.-led research on privacy and security, potentially affecting collaborations with international tech firms or health organizations.

Main Stakeholders Affected

• Healthcare Providers and Plans: Doctors, hospitals, insurers, and clinics that handle administrative tasks and patient data; they stand to gain efficiency but must adapt to AI tools.
• Patients: Individuals whose data privacy and security are prioritized, with potential benefits from improved services.
• AI and Technology Developers: Companies creating AI software for healthcare, who will inform the study and may shape future regulations.
• Government Entities: HHS and its sub-agencies (e.g., Office for Civil Rights, National Coordinator for Health IT), plus congressional committees overseeing the report.
• Advocacy and Research Groups: Civil rights experts, patient privacy advocates, academic institutions, and nonprofits focused on health equity and technology ethics.
• IT Vendors and Cybersecurity Firms: Those providing tools to healthcare, affected by recommendations on threat detection.

Notable Legal, Constitutional, or Political Implications

• Legal: Reinforces HIPAA compliance without new mandates, potentially setting the stage for future regulations on AI in healthcare. It highlights the need to balance innovation with privacy rights under the Fourth Amendment (protection against unreasonable searches, applicable to data security).
• Constitutional: No direct challenges; the bill supports government oversight of emerging technologies in a regulated industry, aligning with Congress's authority to regulate interstate commerce (healthcare) under Article I.
• Political: Bipartisan introduction (by Reps. Hernandez and Lieu) signals broad interest in AI's role in addressing healthcare costs and burnout, a non-partisan issue. The emphasis on consultations with diverse stakeholders promotes inclusive policymaking, but implementation could spark debates on federal overreach in private-sector AI adoption or equity in technology access.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rescom. Hernández, Pablo Jose [D-PR-At Large]

Cosponsors (2)

Rep. Lieu, Ted [D-CA-36], Rep. Espaillat, Adriano [D-NY-13]

Recent Actions

• 2026-01-14: Referred to the House Committee on Energy and Commerce.
• 2026-01-14: Introduced in House
• 2026-01-14: Introduced in House

Bill Versions

• AI in Health Care Efficiency and Study Act — issued 2026-01-14 — PDF (6 pages)